Regional Insights North America GLP-1 Receptor Agonist Market Trends North America dominates the GLP-1 receptor agonist market with a 41.8% share in 2025 , driven by the high prevalence of diabetes and obesity, coupled with strong healthcare infrastructure and widespread insurance coverage
Despite the failure of science, L-carnitine feeding as a tool to promote weight loss and improve exercise performance became a multimillion dollar dietary supplement industry with no genuine benefit to the end users
Novo Nordisk currently carries a Zacks Rank of 3, or Hold, while peers Liquidia Corporation (NASDAQ: LQDA), Indivior Pharmaceuticals (NASDAQ: INDV), and Immunocore (NASDAQ: IMCR) each carry a Zacks Rank of 1, or Strong Buy
Conventional cell surface markers are often unreliable and vary among cancer types [21, 22]
10.4103/2045-9912.229599 Med Gas Res
Immune Peptide Research Guide An overview of Thymosin Alpha-1 an immune-modulating peptide covering how it is studied in immunology research, its approved use elsewhere, and its research-use-only status in the UK
